Novel Methods for the construction of Biologically Active Natural Products based on a chiron-synthetic strategy
Novel Methods for the construction of Biologically Active Natural Products based on a chiron-synthetic strategy
批准号:
10640516
负责人:
YODA Hidemi
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
我们已经recently reported novel and stereoselective methods for the homochiral construction of homochirallactam derivatives elaborated from tartaric acid, sugar, glutamic acid as a chiral pool,and demonsrtated the possibility for the total synthesis of biologically active alkaloids employing这些compouds.In this conection we wish to communicate two results that a stereoselection route toenantiomerically and diastereomerically pure pentasubstituted pyrrolidines has been developed byusing reductive deoxygenation and/or stereoselective reduction of quaternary α-hydroxy - bocpyrrolidine derivatives prepared from alkylation of the functionalized homochiral lactams. In thelatter case, especially,it could proceed through the predominant attack of H i D1 on the carbonyl function from the topface of the 6 -membered metal-chalate rather than five-membered one due to the shielding effect ofthe three large functional groups.Finally,an efficient and stereodefined process was描述为第一个asymmetric synthesis of atetrasubstituted pyrrolidine alkaloid, broussonetine C,as a potent β-galactosidase and β-mannosidase inhibitor by featuring the elaboration through thisstereoselective reduction方法。
英文摘要
We have recently reported novel and stereoselective methods for the construction of homochiral lactam derivatives elaborated from tartaric acid, sugar, and glutamic acid as a chiral pool, and demonsrtated the possibility for the total synthesis of biologically active alkaloids employing these compouds.In this conection we wish to communicate two results that a stereoselective route to enantiomerically and diastereomerically pure pentasubstituted pyrrolidines has been developed by using reductive deoxygenation and/or stereoselective reduction of quaternary α-hydroxy N-Boc pyrrolidine derivatives prepared from alkylation of the functionalized homochiral lactams. In the latter case, especially, it could proceed through the predominant attack of HィイD1-ィエD1 on the carbonyl function from the top face of the six-membered metal-chalate rather than five-membered one due to the shielding effect of the three large functional groups.Finally, an efficient and stereodefined process was described for the first asymmetric synthesis of a tetrasubstituted pyrrolidine alkaloid, broussonetine C, as a potent β-galactosidase and β-mannosidase inhibitor by featuring the elaboration through this stereoselective reduction method.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hidemi Yoda: "Stereoselective Synthesis of Tetrasubstituted Furan from Dihydroxyacetone Dimer"Synlett. 855-856 (1998)
Hidemi Yoda:“从二羟基丙酮二聚体立体选择性合成四取代呋喃”Synlett。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H. Yoda, T. Shimojo, and K. Takabe: "Asymmetric Synthesis of Tetrasubstituted Tetrahydrofuran, 2-Epigoniothalesdiol, Employing C2-Symmetrical Imide."Synlett. 1969-1971 (1999)
H. Yoda、T. Shimojo 和 K. Takabe:“采用 C2-对称酰亚胺,不对称合成四取代四氢呋喃、2-表庚二醇”。Synlett。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hidemi Yoda: "First Total Synthesis of a New Tetrasubstituted Pyrolidine Alkaloids,Broussonetine C"Tetrahedron Letters. 40. 1335-1336 (1999)
Hidemi Yoda:“首次全合成新的四取代吡咯烷生物碱,Broussonetine C”四面体字母。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hidemi Yoda: "Asymmetric Synthesis of Tetrasubstituted Tetrahydrofuran,2-Epigoniothalesdiol, Employing C2-Symmetrical Imides"Synlett. 12. 1969-1971 (1999)
Hidemi Yoda:“使用 C2-对称酰亚胺,不对称合成四取代四氢呋喃,2-Epigoniothalesdiol”Synlett。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hidemi YODA: "First Total Synthesis of a New Tetrasubstituted Pyrrolidine Alkaloid,Broussonetine C" Tetrahedron Letters. 40 (in press). (1999)
Hidemi YODA:“首次全合成新的四取代吡咯烷生物碱,Broussonetine C”四面体字母。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Development of novel bioactive organo-medicinal compounds against metabolic syndrome
-
批准号:22550032
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2010
-
负责人:YODA Hidemi
-
依托单位:
Asymmetric hydroxylation based on the Lewis acid-induced weak interaction and its application to the synthesis of natural products
-
批准号:18550031
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.73万
-
财政年份:2006
-
负责人:YODA Hidemi
-
依托单位:
Novel Tandem Desulfurization and Hydroxylation in Aqueous Media (Towards the Asymmetric Synthesis of New and Effective Anti-cancer Agents)
-
批准号:15550031
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2003
-
负责人:YODA Hidemi
-
依托单位:
New Development of One-electron Transfer Reaction - Application to the Total Synthesis of Biologically Active Natural Products -
-
批准号:13640530
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:YODA Hidemi
-
依托单位:
Construction of Asymmetric Space and Catalytic Stereoselection with C_2-Symmetrical Molecules
-
批准号:06640765
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1994
-
负责人:YODA Hidemi
-
依托单位:
国内基金
海外基金
生物碱Myrrhine、Alkaloid (-)-205B及其类似物的全合成研究
-
批准号:21602088
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2016
-
负责人:黄双平
-
依托单位: